1. A Bayesian Network View on Nested Effects Models. (12th November 2008) Authors: Zeller, Cordula; Fröhlich, Holger; Tresch, Achim Other Names: Repsilber Dirk Academic Editor. Journal: EURASIP journal on bioinformatics and systems biology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Bayesian Network View on Nested Effects Models. (12th November 2008) Authors: Zeller, Cordula; Fröhlich, Holger; Tresch, Achim Other Names: Repsilber Dirk Academic Editor. Journal: EURASIP journal on bioinformatics and systems biology Issue: Volume 2009(2009) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced. Issue 4 (26th January 2021) Authors: Zannad, Faiez; Ferreira, João Pedro; Pocock, Stuart J.; Zeller, Cordula; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Hauske, Sibylle Jenny; Brueckmann, Martina; Pfarr, Egon; Schnee, Janet; Wanner, Christoph; Packer, Milton Journal: Circulation Issue: Volume 143:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study. Issue 4 (December 2015) Authors: Neeland, Ian; McGuire, Darren; Eliasson, Björn; Ridderstråle, Martin; Zeller, Cordula; Woerle, Hans; Broedl, Uli; Johansen, Odd Journal: Diabetes therapy Issue: Volume 6:Issue 4(2015) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure. (14th December 2020) Authors: Packer, Milton; Butler, Javed; Filippatos, Gerasimos; Zannad, Faiez; Ferreira, Joao Pedro; Zeller, Cordula; Brueckmann, Martina; Jamal, Waheed; Pocock, Stuart J.; Anker, Stefan D. Journal: European journal of heart failure Issue: Volume 22:Number 12(2020) Page Start: 2393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME. (11th September 2020) Authors: Pellicori, Pierpaolo; Ofstad, Anne Pernille; Fitchett, David; Zeller, Cordula; Wanner, Christoph; George, Jyothis; Zinman, Bernard; Brueckmann, Martina; Lindenfeld, JoAnn Journal: ESC heart failure Issue: Volume 7:Number 6(2020) Page Start: 3401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. (8th December 2021) Authors: Butler, Javed; Packer, Milton; Filippatos, Gerasimos; Ferreira, Joao Pedro; Zeller, Cordula; Schnee, Janet; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Anker, Stefan D Journal: European heart journal Issue: Volume 43:Number 5(2022) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. (22nd December 2020) Authors: Abraham, William T; Lindenfeld, JoAnn; Ponikowski, Piotr; Agostoni, Piergiuseppe; Butler, Javed; Desai, Akshay S; Filippatos, Gerasimos; Gniot, Jacek; Fu, Michael; Gullestad, Lars; Howlett, Jonathan G; Nicholls, Stephen J; Redon, Josep; Schenkenberger, Isabelle; Silva-Cardoso, José; Störk, Stefan... Journal: European heart journal Issue: Volume 42:Number 6(2021) Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial. Issue 4 (26th January 2021) Authors: Packer, Milton; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J.; Carson, Peter; Anand, Inder; Doehner, Wolfram; Haass, Markus; Komajda, Michel; Miller, Alan; Pehrson, Steen; Teerlink, John R.; Brueckmann, Martina; Jamal, Waheed; Zeller, Cordula; Sch... Journal: Circulation Issue: Volume 143:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial. Issue 16 (19th October 2021) Authors: Packer, Milton; Butler, Javed; Zannad, Faiez; Filippatos, Gerasimos; Ferreira, Joao Pedro; Pocock, Stuart J.; Carson, Peter; Anand, Inder; Doehner, Wolfram; Haass, Markus; Komajda, Michel; Miller, Alan; Pehrson, Steen; Teerlink, John R.; Schnaidt, Sven; Zeller, Cordula; Schnee, Janet M.; Anker, S... Journal: Circulation Issue: Volume 144:Issue 16(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗